ANIK
Anika Therapeutics Inc
20.40$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.3% | -39.1% | +71.5% | -14.4% | +6.0% | -64.7% | -35.7% | -47.5% | -140.6% | – | +107.1% | |
| – | -19.8% | -1.1% | +14.9% | +37.8% | +1.4% | +150.3% | -4.5% | +1.2% | -1.9% | -42.9% | -29.5% | |
| – | +38.4% | +52.4% | +71.2% | +90.2% | -44.9% | -11.5% | +105.8% | +29.1% | +6.5% | -13.9% | -23.2% | |
| – | – | +114.8% | +108.6% | +90.9% | -31.2% | +163.4% | -114.3% | – | – | – | – | |
| – | -21.8% | -636.9% | – | – | – | – | – | – | – | – | – | |
| – | +494.0% | +51.9% | -35.9% | -48.2% | -39.3% | -42.4% | +215.9% | +45.6% | -27.5% | +42.5% | -11.7% | |
| – | +264.0% | -77.6% | +84.5% | +302.7% | – | -279.5% | -95.6% | +140.1% | -27.5% | +53.6% | -95.2% | |
| – | – | – | – | – | – | – | -49.1% | -60.6% | – | – | – | |
| – | – | -2,427.7% | – | -9,654.1% | +0.0% | -99.1% | +85.5% | +92.2% | +435.3% | +118.3% | -13.1% | |
| – | – | – | – | +0.0% | +0.0% | -37.3% | -42.6% | +41.3% | -100.0% | – | – | |
| – | -64.0% | -1,315.3% | – | -9,305.1% | -71.8% | -53.6% | +79.6% | -28.4% | +30.3% | +101.3% | -17.1% | |
| – | -71.3% | -161.1% | – | -252.5% | – | -190.1% | – | – | – | – | – | |
| – | -22.3% | -67.2% | +225.2% | -4.9% | +12.9% | -66.5% | -71.5% | -194.6% | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.